Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)

NCT00704132 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: Comparator: sitagliptin phosphate
DRUG: Comparator: placebo (unspecified)

Sponsor

Merck Sharp & Dohme LLC